Estrogen-induced myelotoxicity in dogs: A review.

Exogenous estrogens used for therapeutic purposes or endogenous estrogen sources such as functional Sertoli cell or ovarian granulosa cell tumors may cause bone marrow toxicity in dogs. The condition is characterized by hematologic abnormalities including thrombocytopenia, anemia, and leukocytosis or leukopenia. Despite intensive therapy with blood or platelet-rich transfusions, broad-spectrum antibiotics, steroids, and bone marrow stimulants, prognosis is unfavorable. Due to the the risk of stimulating the development of uterine diseases and the potential for inducing aplastic anemia, estrogen use in dogs is best avoided where possible. This paper describes the causes of estrogen-induced myelotoxicity, the clinical presentation of the patients, the diagnosis, and the treatment options in the dog.

Fecal shedding of Salmonella spp. in dogs.

Rectal swabs from 100 dogs that were admitted to the veterinary clinic and from randomly selected 100 dogs from one kennel were examined for the presence of Salmonella spp. S. Enteritidis was isolated from a household dog and the strain was susceptible to all antibiotics that were tested. S. Typhimurium was isolated from a dog from the kennel and it was sensitive to all the antibiotics except streptomycin and neomycin. Even though, the occurence of Salmonella spp. in the feces of the dogs in this study was low, attention should always be given when handling canine feces or contaminated materials.